leadf
logo-loader
NASDAQ:IOVA

Iovance Biotherapeutics

Receive alerts
Market:
NASDAQ
Market Cap:
$4.66 billion
Price
31.81 USD
Change
0.28%
52 weeks high
41.49
52 weeks low
17.67

In brief

IOVANCE Biotherapeutics is focused on the development and commercialization of autologous cellular immunotherapies optimizing personalized, tumor-directed Tumor Infiltrating Lymphocytes (TIL).